Multidrug resistance-associated ABC transporters - too much of one thing, good for nothing

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• ATP-binding cassette (ABC) transporters are crucial membrane proteins involved in cellular transport.
• Overexpression of specific ABC transporters, such as P-glycoprotein (ABCB1), MRP1 (ABCC1), and BCRP (ABCG2), is a major cause of multidrug resistance (MDR) in cancer.
• This resistance leads to the failure of numerous chemotherapy treatments.

Purpose of the Study:

• To provide a comprehensive overview of the function, substrates, and localization of key MDR-associated ABC transporters.
• To discuss the roles of other ABCC family members (e.g., MRP2-6, CFTR) in cancer and physiology.
• To explore the potential of understanding ABC transporter structure and mechanisms for developing novel chemotherapy targets and strategies against MDR.

Main Methods:

• Literature review and synthesis of existing research on ABC transporters in cancer.
• Analysis of functional data, substrate specificities, and cellular localization of various ABC transporters.
• Examination of physiological roles and genetic polymorphisms impacting ABC transporter function.

Main Results:

• Key ABC transporters (ABCB1, ABCC1, ABCG2) are central to MDR, reducing chemotherapeutic efficacy.
• Other ABCC transporters and CFTR also play significant roles, with implications beyond cancer.
• Understanding ABC transporter mechanisms offers avenues for overcoming both inherited and acquired MDR.

Conclusions:

• Thorough knowledge of ABC transporter structure and function is vital for developing new cancer therapies.
• Targeting ABC transporters and understanding their roles can lead to strategies to combat multidrug resistance.
• Preventing MDR development and employing novel strategies are crucial for improving chemotherapy outcomes.